Advances in the treatment of Crohn's disease and ulcerative

$ 13.50

4.5
(81)
In stock
Description

When used in a treat-to-target approach, therapies for mucosal healing may favorably modify the natural history of inflammatory bowel disease (IBD), reducing the need for steroids and risk of hospitalization.

NEPC20 AGENDA – Connecticut Pharmacists Association

NEPC20 AGENDA – Connecticut Pharmacists Association

Dr. Edward V. Loftus, MD, Rochester, MN, Gastroenterologist

Are Biologics Right for You?

Understanding the clinical significance of disease detected by imaging but not by ileoscopy or biopsy - Mayo Clinic

Digestive Diseases News - Medical Professionals - Mayo Clinic

NEPC20 AGENDA – Connecticut Pharmacists Association

Are Biologics Right for You?

NEPC20 AGENDA – Connecticut Pharmacists Association

Dr. Edward V. Loftus, MD, Rochester, MN, Gastroenterologist